NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow
RecruitingPhase 4NCT06373978
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumption of narcotic doses (primary outcome) and minimizing patients' exposure to narcotics (secondary outcome) following an ultrasound-guided percutaneous needle tenotomy procedure on the lateral elbow.
Study details
- Official title
- A Randomized Controlled Trial: Alternative Post Procedural Analgesia With NSAIDs vs Opioids in Percutaneous Needle Tenotomy of Elbow
- Conditions
- Elbow Pain
- Chronic Pain
- Interventions
- Drug: Diclofenac
- Drug: Tramadol
- Other: Acetaminophen
- Sponsor
- The Cleveland Clinic
- Start date
- 2024-08-12
- Primary completion
- 2027-06-30
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged 18-65 years * Percutaneous Needle Tenotomy of Lateral Elbow Procedure * Ability to take oral medication and willingness to participate in a 2-week follow-up pill counts * Musculoskeletal ultrasound or MRI with diagnosis of tendinosis of the common extensor tendon of the elbow Exclusion Criteria: * • Any full thickness common extensor tendon tear of the elbow * Prior history of elbow surgery * Symptomatic cervical radiculopathy * Concurrent symptoms of the medial elbow * Treatment with another investigational drug or other intervention concurrently or previously that would interfere with postoperative pain control * Psychiatric illness that impedes evaluation of pain and/or narcotics use * No history of inflammatory arthritis, diabetes, chronic regional pain syndrome, connective tissue disease, fibromyalgia or autoimmune disease * No contraindications to NSAIDs or Opioids
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06373978